END CAPPED NUCLEIC ACID MOLECULES
To disclose, regarding nucleic acids that contain modifications at the 5'-end, 3'-end or 5'-end and 3'-ends, compounds that can be used to make the modified nucleic acids, where the modified nucleic acids have improved expression, lower immunogenicity and improved stability compa...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English Japanese |
Published |
12.11.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To disclose, regarding nucleic acids that contain modifications at the 5'-end, 3'-end or 5'-end and 3'-ends, compounds that can be used to make the modified nucleic acids, where the modified nucleic acids have improved expression, lower immunogenicity and improved stability compared to unmodified nucleic acids.SOLUTION: The present invention provides a compound of formula I or a salt thereof.SELECTED DRAWING: None
【課題】5'末端、3'末端、または5'末端および3'末端に改変を含有する核酸に関し、改変核酸を製造するために使用され得る化合物が開示される。改変核酸は、非改変核酸と比較して、発現の改善、より低い免疫原性、および安定性の改善を有する。【解決手段】式Iの化合物またはその塩。【選択図】なし |
---|---|
AbstractList | To disclose, regarding nucleic acids that contain modifications at the 5'-end, 3'-end or 5'-end and 3'-ends, compounds that can be used to make the modified nucleic acids, where the modified nucleic acids have improved expression, lower immunogenicity and improved stability compared to unmodified nucleic acids.SOLUTION: The present invention provides a compound of formula I or a salt thereof.SELECTED DRAWING: None
【課題】5'末端、3'末端、または5'末端および3'末端に改変を含有する核酸に関し、改変核酸を製造するために使用され得る化合物が開示される。改変核酸は、非改変核酸と比較して、発現の改善、より低い免疫原性、および安定性の改善を有する。【解決手段】式Iの化合物またはその塩。【選択図】なし |
Author | SCOTT LOUIS COHEN JOHN LOUIS DIENER CHRISTIAN GAMPE DAVID BARNES-SEEMAN JAMES ROACHE AMY WHITE SARAH WILLIAMS YUAN JUN FREDERIC ZECRI |
Author_xml | – fullname: DAVID BARNES-SEEMAN – fullname: JOHN LOUIS DIENER – fullname: SARAH WILLIAMS – fullname: SCOTT LOUIS COHEN – fullname: YUAN JUN – fullname: CHRISTIAN GAMPE – fullname: JAMES ROACHE – fullname: FREDERIC ZECRI – fullname: AMY WHITE |
BookMark | eNrjYmDJy89L5WRQdPVzUXB2DAhwdVHwC3X2cfV0VnB09nRR8PX3cXUO9XEN5mFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8V4BRgZGBoYWxsaWlo7GRCkCAA_8JAU |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | エンドキャップされた核酸分子 |
ExternalDocumentID | JP2020183399A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_JP2020183399A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:32:07 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Japanese |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_JP2020183399A3 |
Notes | Application Number: JP20200115238 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201112&DB=EPODOC&CC=JP&NR=2020183399A |
ParticipantIDs | epo_espacenet_JP2020183399A |
PublicationCentury | 2000 |
PublicationDate | 20201112 |
PublicationDateYYYYMMDD | 2020-11-12 |
PublicationDate_xml | – month: 11 year: 2020 text: 20201112 day: 12 |
PublicationDecade | 2020 |
PublicationYear | 2020 |
RelatedCompanies | NOVARTIS AG |
RelatedCompanies_xml | – name: NOVARTIS AG |
Score | 3.4235685 |
Snippet | To disclose, regarding nucleic acids that contain modifications at the 5'-end, 3'-end or 5'-end and 3'-ends, compounds that can be used to make the modified... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY DERIVATIVES THEREOF METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY SUGARS |
Title | END CAPPED NUCLEIC ACID MOLECULES |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201112&DB=EPODOC&locale=&CC=JP&NR=2020183399A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6JOpYr0rUi_tvpQZEtSttKPoKvsbSRrCyrocBX_fS-10z3tLcnB5QPufndJ7g7gVpg9IecCvRMEe8MxrdwQnukYsixQFeZ9dLNVvHOc9EaZE07daQveVrEwdZ7Q7zo5IkrUHOW9qvX14v8Si9Z_K5d38gWHPh6CiU_1xjtWaGZaOh36jKc0JTohfsj15PGX5tkIx4Mt2EY7uq_EgT0PVVjKYh1TggPY4cjuvTqE1qvowB5ZlV7rwG7cvHhjsxG-5RFcs4RqZMA5o1qSkYiNiTYgY6rFacRIFrGnY7gJ2ISMDJxr9rezWcjX1mWfQBtd_uIUNKcsXGFLS96bqnB5iWaQ8BBJvSJXNoR7Bt0NjM43Uruwr3oqns60LqBdfX4VlwislbyqD-QHqNx2xA |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFetNq1KtjyiSW5C82ngIku5uaWIei7bSW9k0CaigxUb8-87GVHvqbdmB2QfMfPPt7uwA3Ai9J9K5QHaCYK9ZupFpwtEtLS1ydIVZH2m2zHeO4t5oYgVTe9qAt1UuTPVP6Hf1OSJa1Bztvaz89eL_EItWbyuXt-kLdn3cD8cuVWt2LNFMN1Q6cBlPaEJUQtyAq_Hjr8wxEY69LdjGGLsvzYE9D2RaymIdU4b7sMNR3Xt5AI1X0YYWWZVea8NuVN94Y7M2vuUhXLGYKsTjnFElnpCQ-UTxiE-VKAkZmYTs6Qiuh2xMRhqONftb2Szga_Myj6GJlD_vgGIVuS3M1EjvdFm4vMAwSDiIpE6eyRjCPoHuBkWnG6WX0BqNo3AW-vFDF_akRObW6cYZNMvPr_wcQbZML6rN-QFl4Xm3 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=END+CAPPED+NUCLEIC+ACID+MOLECULES&rft.inventor=DAVID+BARNES-SEEMAN&rft.inventor=JOHN+LOUIS+DIENER&rft.inventor=SARAH+WILLIAMS&rft.inventor=SCOTT+LOUIS+COHEN&rft.inventor=YUAN+JUN&rft.inventor=CHRISTIAN+GAMPE&rft.inventor=JAMES+ROACHE&rft.inventor=FREDERIC+ZECRI&rft.inventor=AMY+WHITE&rft.date=2020-11-12&rft.externalDBID=A&rft.externalDocID=JP2020183399A |